The UroGold 100™ device is characterized by its compact size and modern design. This leads to an especially easy transport and comfortable handling of the device during treatment.
Premium materials and the latest MTS technology guarantee high-quality SoftWave® for an ideal treatment process. MTS offers different applicators for the various indications ranging from an unfocused applicator (OP155) for the treatment of prostate pain and inflammation and erectile performance to an either soft-focused (OE035) or focused applicator (OE050) for the treatment of prostate pain.
Indications for UroGold 100™:
The advantages of the treatment with the UroGold 100™ device are its versatile and professional applicators which make it easy to repeat the treatment on a regular basis. The therapy of urogenital indications is uncomplicated to conduct and highly tolerable for the patient. SoftWave® therapy features a long-term effectiveness so as to provide a high degree of satisfaction for both patients and physicians.
Comfortable Outpatient Treatment:
The Softwave therapy is applied onto the affected area that has been determined upfront through ultrasound, palpation or anatomical knowledge. Most importantly, the Softwave therapy with UroGold 100™ is pain-free and thus requires no anaesthesia. No side effects have been reported for the SoftWave® treatment of urogenital disorders.
Dr. Irwin Goldstein, MD is the director of San Diego Sexual Medicine, where he maintains his clinical practice, Director of Sexual Medicine at Alvarado Hospital and Clinical Professor of Surgery at University of California at San Diego. Dr. Goldstein has had a long career providing medical help to those with sexual problems, having been involved with sexual dysfunction research since the late 1970′s. Dr. Goldstein holds a bachelor’s degree in engineering from Brown University, with an honors thesis in biomedical engineering. In 1975, he graduated from McGill University Faculty of Medicine in his hometown of Montreal, Quebec, Canada. More.
Dr Brent Sharpe from Georgia Urology interview about the effects and success of ESWT for improved erectile Function.
The UroGold 100™ represents an innovative treatment
option that utilizes the biological effects of SoftWaves® by stimulating the self-healing mechanism of the affected tissue on cellular level. SoftWave® promote the generation of new blood vessels and the release of angiogenic growth factors. It has been shown that they also initiate the migration of stem cells and therefore help improve the blood flow in the treated area. In addition, Softwave-induced revascularization processes can alleviate pain. The combination of all mentioned factors leads to reductions in muscle tension, spasticity and pain for prostate pain and inflammation as well as the long-term recovery of the erection function of the patient. The reduction of plaque size and improvement of penile angulation is another healing factor for patients with prostate pain.